Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentosan polysulfate sodium for mucopolysaccharidosis type VI
RBR-2tz9dkyPhase 2Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jun 2021
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pentosan polysulfate sodium in mucopolysaccharidosis type VI, sponsored by Hospital de Clínicas de Porto Alegre. Started Jun 2021; status: completed.
02
Drugs
pentosan polysulfate sodium
03
Conditions
mucopolysaccharidosis type VI
Beyond the preview
Go deeper on RBR-2tz9dky.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2tz9dky.